European Archives - Page 42 of 1261 - European Medical Journal

ESC 2025: Digitoxin Trial Redefines Role of Glycosides in Heart Failure

DIGIT-HF shows digitoxin reduces death and hospitalisation in advanced heart failure, offering an additional option for high-risk patients on top of standard therapy.

ESC 2025: Age Drives Arrhythmia Risk While Fitness Offers Protection

A large study finds age strongly increases arrhythmia risk, while higher fitness levels protect against atrial ectopy in asymptomatic adults.

Can a New Biomarker Improve Bladder Cancer Detection?

With limited early-detection tools and only modest improvements in survival for advanced disease, clinicians urgently need reliable biomarkers to improve prognostication.

Airway Bacteria Show Protective Effect in Pneumonia and Flu

Airway bacteria like Streptococcus oralis may boost natural immune defences, helping protect against pneumonia and viral infections, new research suggests.

CML Study Reveals Transcript Type Influences Imatinib Effectiveness

A study finds that CML patients with the e13a2 BCR-ABL1 transcript show poorer molecular responses to imatinib compared to those with e14a2, suggesting transcript type may influence treatment outcomes.

ESC 2025: CPR Devices Put to the Test in Zero Gravity

Automatic chest compression devices outperform manual methods for CPR in simulated zero gravity, with piston devices meeting guideline-recommended standards.

ESC 2025: Ethnic Differences Shape Cardiovascular Outcomes in Hypertension

A major analysis finds Afro-American patients with hypertension face higher cardiovascular morbidity, while Asian patients carry a greater risk of stroke.

Reducing Hidden Costs of Childhood Food Allergy Management

A recent mixed-methods study evaluated NOURISH-US, a revised food-supplement programme designed to ease costs for households with a child aged 12 or younger managing any food allergy.

Steatotic Liver Disease Increases Risk of Atrial Fibrillation

This nationwide South Korean cohort study examined over six million young adults aged 20–39 years to assess new-onset AF according to contemporary SLD subtypes.

Transfusions After Rheumatoid Arthritis Joint Surgery Tied to Serious Risks

A nationwide study of more than 66,000 rheumatoid arthritis patients undergoing joint replacement found that blood transfusions are declining but remain linked to higher complication risks, especially in older adults and those with comorbidities.